[ad_1]
The measles, mumps, and rubella vaccine, known as the MMR II vaccine, may act as a shield against the coronavirus until COVID-19 vaccines are available to the public. This is one of the alternatives proposed to stop the spread of the coronavirus, according to a new study published in the scientific journal “mBio”, he writes DarikNews.bg.
Until now, experts have posed this problem as a simple hypothesis, but the new study also provides evidence that the levels of IgG antibodies against coronavirus in patients vaccinated with Merck-produced MMR ii are inversely proportional to the severity of the disease in cured patients. of the illness.
Oxford vaccine against COVID-19 was 70% effective
This vaccine contains the Edmonston measles strain, Jeryl Lynn mumps strain (level B), and Wistar RA 27/3 rubella strain.
“The data obtained indicates that the MMR vaccine can be a protective wall against COVID-19. This may also explain why children have a much lower incidence of COVID-19 than adults, as well as a much lower mortality rate. Most children get their first MMR vaccine between 12 and 15 months and the second between 4 and 6 years, ”said study team leader Jeffrey E. Gold.
To conduct this study, the researchers divided 80 people into two groups. In the first there are 50 people born in the United States with MMR antibodies to the MMR II vaccine. The second group included the remaining 30 volunteers who did not receive the MMR II vaccine but who had MMR antibodies after measles, mumps, or rubella.
Using data from these groups, the researchers found that the higher the level of mumps antibodies produced by the MMR vaccine, the lower the severity of the coronavirus infection, regardless of the age of the patient.
Asymptomatic COVID-19 carriers get sick faster
“This is the first immunological study to evaluate the link between the MMR II vaccine and COVID-19,” added study co-author David J. Hurley, professor and molecular microbiologist at the University of Georgia.
“The MMR II vaccine is considered a safe vaccine with very few side effects. And if it provides the added benefit of preventing COVID-19 infection, preventing its spread, reducing the severity of the disease, or a combination of all these benefits, then It is a very high risk, low risk intervention.
READ ALL ABOUT CORONAVIRUS IN OUR COUNTRY AND THROUGHOUT THE WORLD HERE
To be the first to know the news from Bulgaria and the world, download the new NOVA app – for Android HERE or iOS (Apple) HERE.
Subscribe FREE to the nova.bg newsletter HEREto receive the most important news of the day in your email.
[ad_2]
